Published: 5 September 2024

Publications

Quarterly summary of recent safety communications

Published: 5 September 2024
Prescriber Update 45(3): 56
September 2024

The table below is a summary of recent safety communications for healthcare professionals and consumers. Click on a specific topic to go to the communication.

Date	Communication	Topic
2/9/2024	Dear Healthcare Professional Letter	Copaxone (Glatiramer acetate) 20 mg/mL and 40 mg/mL – Long term anaphylactic reactions (PDF, 3 pages, 406 KB)
22/08/2024	Consultation	Proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Clinical Trials
8/08/2024	Monitoring	Direct-acting oral anticoagulants and potential for patients to experience mood changes
09/07/2024	Monitoring	Update - DPP-4 inhibitors and the possible risk of ileus
22/05/2024	Dear Healthcare Professional Letter	ClopineCENTRAL - update related to recent migration to ClopineCENTRAL 2.0 (PDF, 2 pages, 442 KB)